Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,415 | -1,481 | -26,896 | -26,305 | -13,412 |
| Depreciation Amortization | 1,346 | 5,036 | 3,641 | 2,346 | 1,178 |
| Accounts payable and accrued liabilities | -1,161 | 76 | 1,653 | 174 | -617 |
| Other Working Capital | -1,745 | 4,072 | 46,893 | 42,648 | 41,290 |
| Other Operating Activity | 1,626 | 889 | -6,495 | 4,278 | 3,008 |
| Operating Cash Flow | $-8,349 | $8,592 | $18,796 | $23,141 | $31,447 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,900 | -21,489 | -36,668 | -20,997 | -11,286 |
| PPE Investments | -24 | -9,149 | -8,467 | -6,824 | -2,196 |
| Investing Cash Flow | $17,876 | $-30,638 | $-45,135 | $-27,821 | $-13,482 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,806 | 14,806 | 14,806 | N/A |
| Debt Repayment | -1,161 | -2,088 | -1,758 | -2,417 | -728 |
| Common Stock Issued | N/A | 17,049 | 16,935 | 563 | 44 |
| Other Financing Activity | 0 | -7,500 | -7,500 | -7,500 | -7,500 |
| Financing Cash Flow | $-1,161 | $22,267 | $22,483 | $5,452 | $-8,184 |
| Beginning Cash Position | 13,671 | 13,450 | 13,450 | 13,450 | 13,450 |
| End Cash Position | 22,037 | 13,671 | 9,594 | 14,222 | 23,231 |
| Net Cash Flow | $8,366 | $221 | $-3,856 | $772 | $9,781 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,349 | 8,592 | 18,796 | 23,141 | 31,447 |
| Capital Expenditure | -24 | -9,178 | -8,467 | -6,824 | -2,196 |
| Free Cash Flow | -8,373 | -586 | 10,329 | 16,317 | 29,251 |